Perfusion Scintigraphy in Assessment of Results of Course Treatment with Trimetazidine of Patients with Ischemic Heart Disease

V. I. Chernov, A. A. Garganeeva, J. V. Vesnina, Yu B. Lishmanov

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Course treatment with trimetazidine (60 mg/day, 14 days) in 14 patients with chronic coronary artery disease led to significant reduction of daily requirement in nitroglycerin, number of anginal attacks, decrease of intensity and duration of angina, and increase of tolerance to physical exercise. Effect of trimetazidine on myocardial perfusion in these patients was studied by single photon emission computer tomography (SPECT) with thallium (Tl)-199. Trimetazidine therapy resulted in significant reduction of average size of persistent perfusion defects and simultaneous increase (by 45%) of minimal level of Tl-199 uptake in the fixed perfusion defects. Improvement of myocardial perfusion caused by trimetazidine was also evidenced by significant reduction of size of reversible perfusion defects (on the average by 90%). These results were indicative of positive effect of trimetazidine on metabolism of ischemic myocardium and coronary blood flow in patients with chronic coronary artery disease.

Original languageEnglish
Pages (from-to)14-16
Number of pages3
JournalKardiologiya
Volume41
Issue number8
Publication statusPublished - 2001

Fingerprint

Trimetazidine
Perfusion Imaging
Myocardial Ischemia
Perfusion
Thallium
Coronary Artery Disease
Therapeutics
Nitroglycerin
Photons
Myocardium
Tomography
Exercise

Keywords

  • Coronary artery disease
  • Myocardial scintigraphy
  • Thallium-199
  • Trimetazidine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Perfusion Scintigraphy in Assessment of Results of Course Treatment with Trimetazidine of Patients with Ischemic Heart Disease. / Chernov, V. I.; Garganeeva, A. A.; Vesnina, J. V.; Lishmanov, Yu B.

In: Kardiologiya, Vol. 41, No. 8, 2001, p. 14-16.

Research output: Contribution to journalArticle

@article{e811dd61112740d7b9dd014db7595078,
title = "Perfusion Scintigraphy in Assessment of Results of Course Treatment with Trimetazidine of Patients with Ischemic Heart Disease",
abstract = "Course treatment with trimetazidine (60 mg/day, 14 days) in 14 patients with chronic coronary artery disease led to significant reduction of daily requirement in nitroglycerin, number of anginal attacks, decrease of intensity and duration of angina, and increase of tolerance to physical exercise. Effect of trimetazidine on myocardial perfusion in these patients was studied by single photon emission computer tomography (SPECT) with thallium (Tl)-199. Trimetazidine therapy resulted in significant reduction of average size of persistent perfusion defects and simultaneous increase (by 45{\%}) of minimal level of Tl-199 uptake in the fixed perfusion defects. Improvement of myocardial perfusion caused by trimetazidine was also evidenced by significant reduction of size of reversible perfusion defects (on the average by 90{\%}). These results were indicative of positive effect of trimetazidine on metabolism of ischemic myocardium and coronary blood flow in patients with chronic coronary artery disease.",
keywords = "Coronary artery disease, Myocardial scintigraphy, Thallium-199, Trimetazidine",
author = "Chernov, {V. I.} and Garganeeva, {A. A.} and Vesnina, {J. V.} and Lishmanov, {Yu B.}",
year = "2001",
language = "English",
volume = "41",
pages = "14--16",
journal = "Kardiologiya",
issn = "0022-9040",
publisher = "Media Sfera",
number = "8",

}

TY - JOUR

T1 - Perfusion Scintigraphy in Assessment of Results of Course Treatment with Trimetazidine of Patients with Ischemic Heart Disease

AU - Chernov, V. I.

AU - Garganeeva, A. A.

AU - Vesnina, J. V.

AU - Lishmanov, Yu B.

PY - 2001

Y1 - 2001

N2 - Course treatment with trimetazidine (60 mg/day, 14 days) in 14 patients with chronic coronary artery disease led to significant reduction of daily requirement in nitroglycerin, number of anginal attacks, decrease of intensity and duration of angina, and increase of tolerance to physical exercise. Effect of trimetazidine on myocardial perfusion in these patients was studied by single photon emission computer tomography (SPECT) with thallium (Tl)-199. Trimetazidine therapy resulted in significant reduction of average size of persistent perfusion defects and simultaneous increase (by 45%) of minimal level of Tl-199 uptake in the fixed perfusion defects. Improvement of myocardial perfusion caused by trimetazidine was also evidenced by significant reduction of size of reversible perfusion defects (on the average by 90%). These results were indicative of positive effect of trimetazidine on metabolism of ischemic myocardium and coronary blood flow in patients with chronic coronary artery disease.

AB - Course treatment with trimetazidine (60 mg/day, 14 days) in 14 patients with chronic coronary artery disease led to significant reduction of daily requirement in nitroglycerin, number of anginal attacks, decrease of intensity and duration of angina, and increase of tolerance to physical exercise. Effect of trimetazidine on myocardial perfusion in these patients was studied by single photon emission computer tomography (SPECT) with thallium (Tl)-199. Trimetazidine therapy resulted in significant reduction of average size of persistent perfusion defects and simultaneous increase (by 45%) of minimal level of Tl-199 uptake in the fixed perfusion defects. Improvement of myocardial perfusion caused by trimetazidine was also evidenced by significant reduction of size of reversible perfusion defects (on the average by 90%). These results were indicative of positive effect of trimetazidine on metabolism of ischemic myocardium and coronary blood flow in patients with chronic coronary artery disease.

KW - Coronary artery disease

KW - Myocardial scintigraphy

KW - Thallium-199

KW - Trimetazidine

UR - http://www.scopus.com/inward/record.url?scp=0346367610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346367610&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 14

EP - 16

JO - Kardiologiya

JF - Kardiologiya

SN - 0022-9040

IS - 8

ER -